Role of Brihat Varunadi Kwath with Shveta Parpati in renal calculus.

Clinico-Anatomical Study of Mootravaha Srotas in Mootrashmari w.s.r. to therapeutic effect of Brihat Varunadi kwatha & Shveta Parpati

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027073

Enrollment

Registered

2020-08-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

Intervention1: Brihat Varunadi Kwath & Shveta Parpati: Brihat Varunadi Kwath-30 ml. and Shveta Parpati-250 mg BD Orally for 1 months Control Intervention1: Hospital medicine by doctors to patients in

Eligibility

Inclusion criteria

Inclusion criteria: Clinically and pathologically diagnosed patients of all types of Mootrashmaris.Size of calculus should not be less than 10 mm.

Exclusion criteria

Exclusion criteria: Patients of Benign Prostatic Hyperplasia,Renal failure, renal tuberculosis, diabetes mellitus, Multiple urinary stones and suffering from any other systemic disorder.

Design outcomes

Primary

Measure	Time frame
Improvement in subjective and objective parameterTimepoint: Follow up at 15 day Interval	—

Secondary

Measure	Time frame
To find out the efficacy of treatmentTimepoint: 1 month	—

Countries

India

Contacts

Public ContactSuljeet Baranda

University College of Ayurved Jodhpur

rksharma_jumbo@yahoo.co.in9166216760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026